Click for best price
Tardive Dyskinesia TD Treatment Drugs Market Size, Share 2022
Tardive dyskinesia is a type of neurological disorder, which characterized the blink your eyes fast, chew, smack or pucker of lips, puff out your cheeks, tongue and others. The patients treating with neuroleptic drugs or anti-psychotic medications can also be the cause of tardive dyskinesia. Tardive dyskinesia is difficult to treat as treatment process is also not confirmed and the drug is also not approved in various conditions. The treatment of tardive dyskinesia is directly affect the neurological system of the respective patients. This disorder may commonly occurs in smoker than non-smoker, and also in the patient of depression, anxiety disorder and others.
This report contains market size and forecasts of Tardive Dyskinesia (TD) Treatment Drugs in Global, including the following market information:
Global Tardive Dyskinesia (TD) Treatment Drugs Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global top five companies in 2021 (%)
The global Tardive Dyskinesia (TD) Treatment Drugs market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Valbenazine Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Tardive Dyskinesia (TD) Treatment Drugs include Neurocrine Biosciences, Inc., Teva Pharmaceutical Industries, Pfizer Inc., Biogen, Novartis AG, AstraZeneca, GlaxoSmithKline plc., Bayer AG and Sanofi. etc. In 2021, the global top five players have a share approximately % in terms of revenue.
We surveyed the Tardive Dyskinesia (TD) Treatment Drugs companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Tardive Dyskinesia (TD) Treatment Drugs Market, by Type, 2017-2022, 2023-2028 ($ millions)
Global Tardive Dyskinesia (TD) Treatment Drugs Market Segment Percentages, by Type, 2021 (%)
Valbenazine
Deutetrabenazine
Global Tardive Dyskinesia (TD) Treatment Drugs Market, by Application, 2017-2022, 2023-2028 ($ millions)
Global Tardive Dyskinesia (TD) Treatment Drugs Market Segment Percentages, by Application, 2021 (%)
Hospitals
Clinic
Others
Global Tardive Dyskinesia (TD) Treatment Drugs Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)
Global Tardive Dyskinesia (TD) Treatment Drugs Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Tardive Dyskinesia (TD) Treatment Drugs revenues in global market, 2017-2022 (estimated), ($ millions)
Key companies Tardive Dyskinesia (TD) Treatment Drugs revenues share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Neurocrine Biosciences, Inc.
Teva Pharmaceutical Industries
Pfizer Inc.
Biogen
Novartis AG
AstraZeneca
GlaxoSmithKline plc.
Bayer AG
Sanofi
| Report Attributes |
Report Details |
| Report Title |
Tardive Dyskinesia (TD) Treatment Drugs Market - Global Outlook and Forecast 2022-2028 |
| Historical Year |
2018 to 2022 (Data from 2010 can be provided as per availability) |
| Base Year |
2021 |
| Forecast Year |
2029 |
| Number of Pages |
67 Pages |
| Customization Available |
Yes, the report can be customized as per your need. |
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 Tardive Dyskinesia (TD) Treatment Drugs Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Tardive Dyskinesia (TD) Treatment Drugs Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Tardive Dyskinesia (TD) Treatment Drugs Overall Market Size
2.1 Global Tardive Dyskinesia (TD) Treatment Drugs Market Size: 2021 VS 2028
2.2 Global Tardive Dyskinesia (TD) Treatment Drugs Market Size, Prospects & Forecasts: 2017-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Tardive Dyskinesia (TD) Treatment Drugs Players in Global Market
3.2 Top Global Tardive Dyskinesia (TD) Treatment Drugs Companies Ranked by Revenue
3.3 Global Tardive Dyskinesia (TD) Treatment Drugs Revenue by Companies
3.4 Top 3 and Top 5 Tardive Dyskinesia (TD) Treatment Drugs Companies in Global Market, by Revenue in 2021
3.5 Global Companies Tardive Dyskinesia (TD) Treatment Drugs Product Type
3.6 Tier 1, Tier 2 and Tier 3 Tardive Dyskinesia (TD) Treatment Drugs Players in Global Market
3.6.1 List of Global Tier 1 Tardive Dyskinesia (TD) Treatment Drugs Companies
3.6.2 List of Global Tier 2 and Tier 3 Tardive Dyskinesia (TD) Treatment Drugs Companies
4 Market Sights by Product
4.1 Overview
4.1.1 by Type - Global Tardive Dyskinesia (TD) Treatment Drugs Market Size Markets, 2021 & 2028
4.1.2 Valbenazine
4.1.3 Deutetrabenazine
4.2 By Type - Global Tardive Dyskinesia (TD) Treatment Drugs Revenue & Forecasts
4.2.1 By Type - Global Tardive Dyskinesia (TD) Treatment Drugs Revenue, 2017-2022
4.2.2 By Type - Global Tardive Dyskinesia (TD) Treatment Drugs Revenue, 2023-2028
4.2.3 By Type - Global Tardive Dyskinesia (TD) Treatment Drugs Revenue Market Share, 2017-2028
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Tardive Dyskinesia (TD) Treatment Drugs Market Size, 2021 & 2028
5.1.2 Hospitals
5.1.3 Clinic
5.1.4 Others
5.2 By Application - Global Tardive Dyskinesia (TD) Treatment Drugs Revenue & Forecasts
5.2.1 By Application - Global Tardive Dyskinesia (TD) Treatment Drugs Revenue, 2017-2022
5.2.2 By Application - Global Tardive Dyskinesia (TD) Treatment Drugs Revenue, 2023-2028
5.2.3 By Application - Global Tardive Dyskinesia (TD) Treatment Drugs Revenue Market Share, 2017-2028
6 Sights by Region
6.1 By Region - Global Tardive Dyskinesia (TD) Treatment Drugs Market Size, 2021 & 2028
6.2 By Region - Global Tardive Dyskinesia (TD) Treatment Drugs Revenue & Forecasts
6.2.1 By Region - Global Tardive Dyskinesia (TD) Treatment Drugs Revenue, 2017-2022
6.2.2 By Region - Global Tardive Dyskinesia (TD) Treatment Drugs Revenue, 2023-2028
6.2.3 By Region - Global Tardive Dyskinesia (TD) Treatment Drugs Revenue Market Share, 2017-2028
6.3 North America
6.3.1 By Country - North America Tardive Dyskinesia (TD) Treatment Drugs Revenue, 2017-2028
6.3.2 US Tardive Dyskinesia (TD) Treatment Drugs Market Size, 2017-2028
6.3.3 Canada Tardive Dyskinesia (TD) Treatment Drugs Market Size, 2017-2028
6.3.4 Mexico Tardive Dyskinesia (TD) Treatment Drugs Market Size, 2017-2028
6.4 Europe
6.4.1 By Country - Europe Tardive Dyskinesia (TD) Treatment Drugs Revenue, 2017-2028
6.4.2 Germany Tardive Dyskinesia (TD) Treatment Drugs Market Size, 2017-2028
6.4.3 France Tardive Dyskinesia (TD) Treatment Drugs Market Size, 2017-2028
6.4.4 U.K. Tardive Dyskinesia (TD) Treatment Drugs Market Size, 2017-2028
6.4.5 Italy Tardive Dyskinesia (TD) Treatment Drugs Market Size, 2017-2028
6.4.6 Russia Tardive Dyskinesia (TD) Treatment Drugs Market Size, 2017-2028
6.4.7 Nordic Countries Tardive Dyskinesia (TD) Treatment Drugs Market Size, 2017-2028
6.4.8 Benelux Tardive Dyskinesia (TD) Treatment Drugs Market Size, 2017-2028
6.5 Asia
6.5.1 By Region - Asia Tardive Dyskinesia (TD) Treatment Drugs Revenue, 2017-2028
6.5.2 China Tardive Dyskinesia (TD) Treatment Drugs Market Size, 2017-2028
6.5.3 Japan Tardive Dyskinesia (TD) Treatment Drugs Market Size, 2017-2028
6.5.4 South Korea Tardive Dyskinesia (TD) Treatment Drugs Market Size, 2017-2028
6.5.5 Southeast Asia Tardive Dyskinesia (TD) Treatment Drugs Market Size, 2017-2028
6.5.6 India Tardive Dyskinesia (TD) Treatment Drugs Market Size, 2017-2028
6.6 South America
6.6.1 By Country - South America Tardive Dyskinesia (TD) Treatment Drugs Revenue, 2017-2028
6.6.2 Brazil Tardive Dyskinesia (TD) Treatment Drugs Market Size, 2017-2028
6.6.3 Argentina Tardive Dyskinesia (TD) Treatment Drugs Market Size, 2017-2028
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Tardive Dyskinesia (TD) Treatment Drugs Revenue, 2017-2028
6.7.2 Turkey Tardive Dyskinesia (TD) Treatment Drugs Market Size, 2017-2028
6.7.3 Israel Tardive Dyskinesia (TD) Treatment Drugs Market Size, 2017-2028
6.7.4 Saudi Arabia Tardive Dyskinesia (TD) Treatment Drugs Market Size, 2017-2028
6.7.5 UAE Tardive Dyskinesia (TD) Treatment Drugs Market Size, 2017-2028
7 Players Profiles
7.1 Neurocrine Biosciences, Inc.
7.1.1 Neurocrine Biosciences, Inc. Corporate Summary
7.1.2 Neurocrine Biosciences, Inc. Business Overview
7.1.3 Neurocrine Biosciences, Inc. Tardive Dyskinesia (TD) Treatment Drugs Major Product Offerings
7.1.4 Neurocrine Biosciences, Inc. Tardive Dyskinesia (TD) Treatment Drugs Revenue in Global Market (2017-2022)
7.1.5 Neurocrine Biosciences, Inc. Key News
7.2 Teva Pharmaceutical Industries
7.2.1 Teva Pharmaceutical Industries Corporate Summary
7.2.2 Teva Pharmaceutical Industries Business Overview
7.2.3 Teva Pharmaceutical Industries Tardive Dyskinesia (TD) Treatment Drugs Major Product Offerings
7.2.4 Teva Pharmaceutical Industries Tardive Dyskinesia (TD) Treatment Drugs Revenue in Global Market (2017-2022)
7.2.5 Teva Pharmaceutical Industries Key News
7.3 Pfizer Inc.
7.3.1 Pfizer Inc. Corporate Summary
7.3.2 Pfizer Inc. Business Overview
7.3.3 Pfizer Inc. Tardive Dyskinesia (TD) Treatment Drugs Major Product Offerings
7.3.4 Pfizer Inc. Tardive Dyskinesia (TD) Treatment Drugs Revenue in Global Market (2017-2022)
7.3.5 Pfizer Inc. Key News
7.4 Biogen
7.4.1 Biogen Corporate Summary
7.4.2 Biogen Business Overview
7.4.3 Biogen Tardive Dyskinesia (TD) Treatment Drugs Major Product Offerings
7.4.4 Biogen Tardive Dyskinesia (TD) Treatment Drugs Revenue in Global Market (2017-2022)
7.4.5 Biogen Key News
7.5 Novartis AG
7.5.1 Novartis AG Corporate Summary
7.5.2 Novartis AG Business Overview
7.5.3 Novartis AG Tardive Dyskinesia (TD) Treatment Drugs Major Product Offerings
7.5.4 Novartis AG Tardive Dyskinesia (TD) Treatment Drugs Revenue in Global Market (2017-2022)
7.5.5 Novartis AG Key News
7.6 AstraZeneca
7.6.1 AstraZeneca Corporate Summary
7.6.2 AstraZeneca Business Overview
7.6.3 AstraZeneca Tardive Dyskinesia (TD) Treatment Drugs Major Product Offerings
7.6.4 AstraZeneca Tardive Dyskinesia (TD) Treatment Drugs Revenue in Global Market (2017-2022)
7.6.5 AstraZeneca Key News
7.7 GlaxoSmithKline plc.
7.7.1 GlaxoSmithKline plc. Corporate Summary
7.7.2 GlaxoSmithKline plc. Business Overview
7.7.3 GlaxoSmithKline plc. Tardive Dyskinesia (TD) Treatment Drugs Major Product Offerings
7.7.4 GlaxoSmithKline plc. Tardive Dyskinesia (TD) Treatment Drugs Revenue in Global Market (2017-2022)
7.7.5 GlaxoSmithKline plc. Key News
7.8 Bayer AG
7.8.1 Bayer AG Corporate Summary
7.8.2 Bayer AG Business Overview
7.8.3 Bayer AG Tardive Dyskinesia (TD) Treatment Drugs Major Product Offerings
7.8.4 Bayer AG Tardive Dyskinesia (TD) Treatment Drugs Revenue in Global Market (2017-2022)
7.8.5 Bayer AG Key News
7.9 Sanofi
7.9.1 Sanofi Corporate Summary
7.9.2 Sanofi Business Overview
7.9.3 Sanofi Tardive Dyskinesia (TD) Treatment Drugs Major Product Offerings
7.9.4 Sanofi Tardive Dyskinesia (TD) Treatment Drugs Revenue in Global Market (2017-2022)
7.9.5 Sanofi Key News
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Tardive Dyskinesia (TD) Treatment Drugs Market Opportunities & Trends in Global Market
Table 2. Tardive Dyskinesia (TD) Treatment Drugs Market Drivers in Global Market
Table 3. Tardive Dyskinesia (TD) Treatment Drugs Market Restraints in Global Market
Table 4. Key Players of Tardive Dyskinesia (TD) Treatment Drugs in Global Market
Table 5. Top Tardive Dyskinesia (TD) Treatment Drugs Players in Global Market, Ranking by Revenue (2021)
Table 6. Global Tardive Dyskinesia (TD) Treatment Drugs Revenue by Companies, (US$, Mn), 2017-2022
Table 7. Global Tardive Dyskinesia (TD) Treatment Drugs Revenue Share by Companies, 2017-2022
Table 8. Global Companies Tardive Dyskinesia (TD) Treatment Drugs Product Type
Table 9. List of Global Tier 1 Tardive Dyskinesia (TD) Treatment Drugs Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Tardive Dyskinesia (TD) Treatment Drugs Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type ? Global Tardive Dyskinesia (TD) Treatment Drugs Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Tardive Dyskinesia (TD) Treatment Drugs Revenue in Global (US$, Mn), 2017-2022
Table 13. By Type - Tardive Dyskinesia (TD) Treatment Drugs Revenue in Global (US$, Mn), 2023-2028
Table 14. By Application ? Global Tardive Dyskinesia (TD) Treatment Drugs Revenue, (US$, Mn), 2021 & 2028
Table 15. By Application - Tardive Dyskinesia (TD) Treatment Drugs Revenue in Global (US$, Mn), 2017-2022
Table 16. By Application - Tardive Dyskinesia (TD) Treatment Drugs Revenue in Global (US$, Mn), 2023-2028
Table 17. By Region ? Global Tardive Dyskinesia (TD) Treatment Drugs Revenue, (US$, Mn), 2021 & 2028
Table 18. By Region - Global Tardive Dyskinesia (TD) Treatment Drugs Revenue (US$, Mn), 2017-2022
Table 19. By Region - Global Tardive Dyskinesia (TD) Treatment Drugs Revenue (US$, Mn), 2023-2028
Table 20. By Country - North America Tardive Dyskinesia (TD) Treatment Drugs Revenue, (US$, Mn), 2017-2022
Table 21. By Country - North America Tardive Dyskinesia (TD) Treatment Drugs Revenue, (US$, Mn), 2023-2028
Table 22. By Country - Europe Tardive Dyskinesia (TD) Treatment Drugs Revenue, (US$, Mn), 2017-2022
Table 23. By Country - Europe Tardive Dyskinesia (TD) Treatment Drugs Revenue, (US$, Mn), 2023-2028
Table 24. By Region - Asia Tardive Dyskinesia (TD) Treatment Drugs Revenue, (US$, Mn), 2017-2022
Table 25. By Region - Asia Tardive Dyskinesia (TD) Treatment Drugs Revenue, (US$, Mn), 2023-2028
Table 26. By Country - South America Tardive Dyskinesia (TD) Treatment Drugs Revenue, (US$, Mn), 2017-2022
Table 27. By Country - South America Tardive Dyskinesia (TD) Treatment Drugs Revenue, (US$, Mn), 2023-2028
Table 28. By Country - Middle East & Africa Tardive Dyskinesia (TD) Treatment Drugs Revenue, (US$, Mn), 2017-2022
Table 29. By Country - Middle East & Africa Tardive Dyskinesia (TD) Treatment Drugs Revenue, (US$, Mn), 2023-2028
Table 30. Neurocrine Biosciences, Inc. Corporate Summary
Table 31. Neurocrine Biosciences, Inc. Tardive Dyskinesia (TD) Treatment Drugs Product Offerings
Table 32. Neurocrine Biosciences, Inc. Tardive Dyskinesia (TD) Treatment Drugs Revenue (US$, Mn), (2017-2022)
Table 33. Teva Pharmaceutical Industries Corporate Summary
Table 34. Teva Pharmaceutical Industries Tardive Dyskinesia (TD) Treatment Drugs Product Offerings
Table 35. Teva Pharmaceutical Industries Tardive Dyskinesia (TD) Treatment Drugs Revenue (US$, Mn), (2017-2022)
Table 36. Pfizer Inc. Corporate Summary
Table 37. Pfizer Inc. Tardive Dyskinesia (TD) Treatment Drugs Product Offerings
Table 38. Pfizer Inc. Tardive Dyskinesia (TD) Treatment Drugs Revenue (US$, Mn), (2017-2022)
Table 39. Biogen Corporate Summary
Table 40. Biogen Tardive Dyskinesia (TD) Treatment Drugs Product Offerings
Table 41. Biogen Tardive Dyskinesia (TD) Treatment Drugs Revenue (US$, Mn), (2017-2022)
Table 42. Novartis AG Corporate Summary
Table 43. Novartis AG Tardive Dyskinesia (TD) Treatment Drugs Product Offerings
Table 44. Novartis AG Tardive Dyskinesia (TD) Treatment Drugs Revenue (US$, Mn), (2017-2022)
Table 45. AstraZeneca Corporate Summary
Table 46. AstraZeneca Tardive Dyskinesia (TD) Treatment Drugs Product Offerings
Table 47. AstraZeneca Tardive Dyskinesia (TD) Treatment Drugs Revenue (US$, Mn), (2017-2022)
Table 48. GlaxoSmithKline plc. Corporate Summary
Table 49. GlaxoSmithKline plc. Tardive Dyskinesia (TD) Treatment Drugs Product Offerings
Table 50. GlaxoSmithKline plc. Tardive Dyskinesia (TD) Treatment Drugs Revenue (US$, Mn), (2017-2022)
Table 51. Bayer AG Corporate Summary
Table 52. Bayer AG Tardive Dyskinesia (TD) Treatment Drugs Product Offerings
Table 53. Bayer AG Tardive Dyskinesia (TD) Treatment Drugs Revenue (US$, Mn), (2017-2022)
Table 54. Sanofi Corporate Summary
Table 55. Sanofi Tardive Dyskinesia (TD) Treatment Drugs Product Offerings
Table 56. Sanofi Tardive Dyskinesia (TD) Treatment Drugs Revenue (US$, Mn), (2017-2022)
List of Figures
Figure 1. Tardive Dyskinesia (TD) Treatment Drugs Segment by Type in 2021
Figure 2. Tardive Dyskinesia (TD) Treatment Drugs Segment by Application in 2021
Figure 3. Global Tardive Dyskinesia (TD) Treatment Drugs Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Tardive Dyskinesia (TD) Treatment Drugs Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Tardive Dyskinesia (TD) Treatment Drugs Revenue, 2017-2028 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Tardive Dyskinesia (TD) Treatment Drugs Revenue in 2021
Figure 8. By Type - Global Tardive Dyskinesia (TD) Treatment Drugs Revenue Market Share, 2017-2028
Figure 9. By Application - Global Tardive Dyskinesia (TD) Treatment Drugs Revenue Market Share, 2017-2028
Figure 10. By Region - Global Tardive Dyskinesia (TD) Treatment Drugs Revenue Market Share, 2017-2028
Figure 11. By Country - North America Tardive Dyskinesia (TD) Treatment Drugs Revenue Market Share, 2017-2028
Figure 12. US Tardive Dyskinesia (TD) Treatment Drugs Revenue, (US$, Mn), 2017-2028
Figure 13. Canada Tardive Dyskinesia (TD) Treatment Drugs Revenue, (US$, Mn), 2017-2028
Figure 14. Mexico Tardive Dyskinesia (TD) Treatment Drugs Revenue, (US$, Mn), 2017-2028
Figure 15. By Country - Europe Tardive Dyskinesia (TD) Treatment Drugs Revenue Market Share, 2017-2028
Figure 16. Germany Tardive Dyskinesia (TD) Treatment Drugs Revenue, (US$, Mn), 2017-2028
Figure 17. France Tardive Dyskinesia (TD) Treatment Drugs Revenue, (US$, Mn), 2017-2028
Figure 18. U.K. Tardive Dyskinesia (TD) Treatment Drugs Revenue, (US$, Mn), 2017-2028
Figure 19. Italy Tardive Dyskinesia (TD) Treatment Drugs Revenue, (US$, Mn), 2017-2028
Figure 20. Russia Tardive Dyskinesia (TD) Treatment Drugs Revenue, (US$, Mn), 2017-2028
Figure 21. Nordic Countries Tardive Dyskinesia (TD) Treatment Drugs Revenue, (US$, Mn), 2017-2028
Figure 22. Benelux Tardive Dyskinesia (TD) Treatment Drugs Revenue, (US$, Mn), 2017-2028
Figure 23. By Region - Asia Tardive Dyskinesia (TD) Treatment Drugs Revenue Market Share, 2017-2028
Figure 24. China Tardive Dyskinesia (TD) Treatment Drugs Revenue, (US$, Mn), 2017-2028
Figure 25. Japan Tardive Dyskinesia (TD) Treatment Drugs Revenue, (US$, Mn), 2017-2028
Figure 26. South Korea Tardive Dyskinesia (TD) Treatment Drugs Revenue, (US$, Mn), 2017-2028
Figure 27. Southeast Asia Tardive Dyskinesia (TD) Treatment Drugs Revenue, (US$, Mn), 2017-2028
Figure 28. India Tardive Dyskinesia (TD) Treatment Drugs Revenue, (US$, Mn), 2017-2028
Figure 29. By Country - South America Tardive Dyskinesia (TD) Treatment Drugs Revenue Market Share, 2017-2028
Figure 30. Brazil Tardive Dyskinesia (TD) Treatment Drugs Revenue, (US$, Mn), 2017-2028
Figure 31. Argentina Tardive Dyskinesia (TD) Treatment Drugs Revenue, (US$, Mn), 2017-2028
Figure 32. By Country - Middle East & Africa Tardive Dyskinesia (TD) Treatment Drugs Revenue Market Share, 2017-2028
Figure 33. Turkey Tardive Dyskinesia (TD) Treatment Drugs Revenue, (US$, Mn), 2017-2028
Figure 34. Israel Tardive Dyskinesia (TD) Treatment Drugs Revenue, (US$, Mn), 2017-2028
Figure 35. Saudi Arabia Tardive Dyskinesia (TD) Treatment Drugs Revenue, (US$, Mn), 2017-2028
Figure 36. UAE Tardive Dyskinesia (TD) Treatment Drugs Revenue, (US$, Mn), 2017-2028
Figure 37. Neurocrine Biosciences, Inc. Tardive Dyskinesia (TD) Treatment Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 38. Teva Pharmaceutical Industries Tardive Dyskinesia (TD) Treatment Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 39. Pfizer Inc. Tardive Dyskinesia (TD) Treatment Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 40. Biogen Tardive Dyskinesia (TD) Treatment Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 41. Novartis AG Tardive Dyskinesia (TD) Treatment Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 42. AstraZeneca Tardive Dyskinesia (TD) Treatment Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 43. GlaxoSmithKline plc. Tardive Dyskinesia (TD) Treatment Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 44. Bayer AG Tardive Dyskinesia (TD) Treatment Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 45. Sanofi Tardive Dyskinesia (TD) Treatment Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
